Annual Current Assets
$10.30 M
+$385.00 K+3.88%
31 December 2023
Summary:
ReShape Lifesciences annual total current assets is currently $10.30 million, with the most recent change of +$385.00 thousand (+3.88%) on 31 December 2023. During the last 3 years, it has fallen by -$19.64 million (-65.61%). RSLS annual current assets is now -82.11% below its all-time high of $57.55 million, reached on 31 December 2007.RSLS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$5.34 M
-$749.00 K-12.30%
30 September 2024
Summary:
ReShape Lifesciences quarterly total current assets is currently $5.34 million, with the most recent change of -$749.00 thousand (-12.30%) on 30 September 2024. Over the past year, it has dropped by -$4.96 million (-48.15%). RSLS quarterly current assets is now -91.86% below its all-time high of $65.61 million, reached on 30 June 2021.RSLS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -48.1% |
| 3 y3 years | -65.6% | -82.2% |
| 5 y5 years | +1.9% | -47.2% |
RSLS Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.6% | +3.9% | -82.2% | at low |
| 5 y | 5 years | -65.6% | +15.1% | -91.9% | at low |
| alltime | all time | -82.1% | +80.0% | -91.9% | +100.4% |
ReShape Lifesciences Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.34 M(-12.3%) |
| June 2024 | - | $6.09 M(-22.9%) |
| Mar 2024 | - | $7.89 M(-23.3%) |
| Dec 2023 | $367.00 K(-70.2%) | $10.30 M(+39.2%) |
| Sept 2023 | - | $7.40 M(-29.8%) |
| June 2023 | - | $10.54 M(-30.8%) |
| Mar 2023 | - | $15.23 M(+53.7%) |
| Dec 2022 | $1.23 M(-94.6%) | $9.91 M(-27.0%) |
| Sept 2022 | - | $13.57 M(-30.3%) |
| June 2022 | - | $19.49 M(-17.5%) |
| Mar 2022 | - | $23.63 M(-21.1%) |
| Dec 2021 | $22.59 M(-19.6%) | $29.94 M(-20.4%) |
| Sept 2021 | - | $37.59 M(-42.7%) |
| June 2021 | - | $65.61 M(+695.2%) |
| Mar 2021 | - | $8.25 M(-7.8%) |
| Dec 2020 | $28.12 M(-4.8%) | $8.94 M(+9.7%) |
| Sept 2020 | - | $8.15 M(-4.6%) |
| June 2020 | - | $8.54 M(+0.4%) |
| Mar 2020 | - | $8.51 M(-15.8%) |
| Dec 2019 | $29.55 M(-21.3%) | $10.11 M(-26.1%) |
| Sept 2019 | - | $13.67 M(+8.2%) |
| June 2019 | - | $12.63 M(+36.8%) |
| Mar 2019 | - | $9.23 M(+5.9%) |
| Dec 2018 | $37.55 M(-49.8%) | $8.72 M(+227.3%) |
| Sept 2018 | - | $2.66 M(-50.0%) |
| June 2018 | - | $5.33 M(+0.1%) |
| Mar 2018 | - | $5.32 M(-61.8%) |
| Dec 2017 | $74.77 M(+5563.8%) | $13.94 M(-45.6%) |
| Sept 2017 | - | $25.61 M(+93.1%) |
| June 2017 | - | $13.26 M(-36.4%) |
| Mar 2017 | - | $20.85 M(+264.5%) |
| Dec 2016 | $1.32 M(+21.8%) | $5.72 M(-40.0%) |
| Sept 2016 | - | $9.54 M(-32.4%) |
| June 2016 | - | $14.12 M(+1.2%) |
| Mar 2016 | - | $13.95 M(+32.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $1.08 M(-20.4%) | $10.50 M(-24.4%) |
| Sept 2015 | - | $13.89 M(+112.6%) |
| June 2015 | - | $6.53 M(-49.8%) |
| Mar 2015 | - | $13.02 M(-0.0%) |
| Dec 2014 | $1.36 M(-2.6%) | $13.02 M(-25.3%) |
| Sept 2014 | - | $17.43 M(-23.9%) |
| June 2014 | - | $22.91 M(-12.4%) |
| Mar 2014 | - | $26.15 M(+4.6%) |
| Dec 2013 | $1.40 M(-17.4%) | $24.99 M(+8.0%) |
| Sept 2013 | - | $23.14 M(-8.4%) |
| June 2013 | - | $25.27 M(-19.9%) |
| Mar 2013 | - | $31.53 M(+29.2%) |
| Dec 2012 | $1.69 M(+84.1%) | $24.40 M(-17.7%) |
| Sept 2012 | - | $29.64 M(+0.5%) |
| June 2012 | - | $29.49 M(+24.8%) |
| Mar 2012 | - | $23.62 M(-25.2%) |
| Dec 2011 | $919.30 K(+4.1%) | $31.57 M(-13.2%) |
| Sept 2011 | - | $36.36 M(+28.4%) |
| June 2011 | - | $28.33 M(-13.8%) |
| Mar 2011 | - | $32.87 M(-13.0%) |
| Dec 2010 | $883.10 K(-20.6%) | $37.80 M(+176.8%) |
| Sept 2010 | - | $13.66 M(+27.5%) |
| June 2010 | - | $10.71 M(-29.3%) |
| Mar 2010 | - | $15.16 M(+0.4%) |
| Dec 2009 | $1.11 M(-25.1%) | $15.10 M(-44.9%) |
| Sept 2009 | - | $27.39 M(-22.5%) |
| June 2009 | - | $35.34 M(-1.3%) |
| Mar 2009 | - | $35.80 M(+33.6%) |
| Dec 2008 | $1.48 M(-0.8%) | $26.79 M(-7.5%) |
| Sept 2008 | - | $28.96 M(-25.8%) |
| June 2008 | - | $39.01 M(-19.8%) |
| Mar 2008 | - | $48.63 M(-15.5%) |
| Dec 2007 | $1.50 M(+35.0%) | $57.55 M(+151.5%) |
| Sept 2007 | - | $22.88 M(-34.5%) |
| Dec 2006 | $1.11 M(+63.3%) | $34.96 M(+221.2%) |
| Dec 2005 | $679.10 K | $10.88 M |
FAQ
- What is ReShape Lifesciences annual total current assets?
- What is the all time high annual current assets for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly total current assets?
- What is the all time high quarterly current assets for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly current assets year-on-year change?
What is ReShape Lifesciences annual total current assets?
The current annual current assets of RSLS is $10.30 M
What is the all time high annual current assets for ReShape Lifesciences?
ReShape Lifesciences all-time high annual total current assets is $57.55 M
What is ReShape Lifesciences quarterly total current assets?
The current quarterly current assets of RSLS is $5.34 M
What is the all time high quarterly current assets for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly total current assets is $65.61 M
What is ReShape Lifesciences quarterly current assets year-on-year change?
Over the past year, RSLS quarterly total current assets has changed by -$4.96 M (-48.15%)